New Multi-Organ-Chip project towards vaccine & drug candidate testing for Tuberculosis
TissUse will receive funding from the Bill & Melinda Gates Foundation to develop a human preclinical lung-liver-lymph no…
TissUse will receive funding from the Bill & Melinda Gates Foundation to develop a human preclinical lung-liver-lymph no…
Billions of injections are administered worldwide on an annual basis. Nonetheless, the conventional approach via hypoder…
Highland Park, NJ—Global Coronaviruses (Covid-19) deadly infection has urged the world’s pharmaceutical scientists and g…
After receiving priority review in 2018, CIMZIA® (certolizumab pegol) is now approved in China for the treatment of Mode…
ARTES Biotechnology announces the acquisition of the unique SplitCore technology developed by scientists at the Universi…
Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform an…
The French R&D tax credit CIR gives French companies the ability to claim tax relief on 30% on all generated costs outso…
ARTES Biotechnology specialized in microbial process development and technology transfer for pharmaceutical industry is…
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has expanded its ra…
Lophius Biosciences GmbH today announced the extension of the first tranche of the recently closed financing round by €5…